TORONTO, ONTARIO--(Marketwired - Dec. 30, 2015) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA OR THROUGH U.S. NEWSWIRE SERVICES

Beleave Inc. (formerly Stream Ventures Inc.) (the "Corporation" or "Beleave") is pleased to announce that the Canadian Securities Exchange ("CSE") has provided final approval to list the Corporation's common shares for trading. Trading of the Corporation's common shares will commence on December 31st, 2015 under the symbol "BE". Information about Beleave can be found in the Corporation's listing statement dated December 23, 2015, which is located on the Corporation's profile at www.sedar.com and on the CSE website. Alternatively you can visitwww.beleave.com for additional information.

About Beleave

Beleave Inc. (formerly Stream Ventures Inc.) is a biotech company committed to becoming a licensed producer under the Marihuana for Medical Purposes Regulations (the "MMPR"). Beleave's wholly-owned subsidiary First Access Medical Inc. ("FAM") has applied for a licence to cultivate and sell medical marihuana...